Derma Scan
DermaScan is a French private healthcare operator running a network of dedicated skin cancer screening centers that use total body photography, video dermoscopy, and a secure patient portal to deliver rapid (under 48 hours) preventive skin examinations to adult patients across France.
- Company typePrivate
- Founded2025
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Derma Scan does
DermaScan is a French private healthcare company (SAS, RCS Paris 939 721 817) operating a network of dedicated skin cancer screening centers. Founded and headquartered in Paris, the company addresses the structural dermatology access gap in France by offering systematic total-body skin examinations with rapid availability (typically within 48 hours), in contrast to the multi-month waits common for traditional dermatology appointments. Its primary customers are adult patients seeking preventive screening, with priority given to those referred by a general practitioner and individuals with elevated risk factors such as family history of skin cancer, more than 50 moles, or high UV exposure.
The core service is built around three integrated components: Cartographie Corporelle Totale (Total Body Mapping) using FotoFinder and Canfield systems, which captures approximately 20 high-resolution standardized photographs per consultation to create a longitudinal reference baseline; video dermoscopy for microscopic analysis of individual lesions, with images tagged to the patient's body map; and a secure proprietary patient portal (app.dermascan.io) hosted on HDS-certified AWS infrastructure with double-factor authentication, giving patients 24/7 access to their images, clinical reports, and prevention advice. An AI Companion feature is announced as upcoming but not yet deployed.
DermaScan monetizes through per-consultation fees with two tiers: €60 with a GP referral letter (effectively €0 out-of-pocket after Sécurité Sociale and mutual insurer reimbursement) and €90 without a referral (~€60 out-of-pocket), plus a €30 fully reimbursed follow-up at three months. All appointments are booked exclusively through Doctolib. The company currently operates four centers (Paris Nord, Paris Bastille, Paris Denfert-Rochereau, and Bordeaux), staffed by over 30 trained GPs and nurses, and has publicly announced a 2026 expansion to twelve additional cities across France and Belgium.
Derma Scan firmographics
Firmographics- Name
- Derma Scan
- Legal name
- DERMASCAN
- Website
- https://dermascan.fr
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- DermaScan is a French private healthcare operator running a network of dedicated skin cancer screening centers that use total body photography, video dermoscopy, and a secure patient portal to deliver rapid (under 48 hours) preventive skin examinations to adult patients across France.
- Ownership category
- akta.pro rank
Derma Scan industry classification
Industry- Product category
- Skin Cancer Screening Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- General & Medical Dermatology (HLAKACAA)
- akta.pro secondary industry
- Dermatopathology (HLAKACAC)
Keywords
Where Derma Scan is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices17 records
Markets served
Derma Scan business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Skin Cancer Screening Consultations: DermaScan charges patients a one-time fee per consultation. Two pricing tiers apply: €60 with a GP referral letter (optimally reimbursed by French Social Security and mutual insurer, resulting in zero out-of-pocket cost) and €90 without a referral (partial reimbursement, ~€60 out-of-pocket). A follow-up consultation at 3 months costs €30 (fully reimbursed). Revenue is generated per clinical encounter, with no subscription component. The company is a SAS incorporated in France, subject to standard French healthcare billing regulations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | With GP referral letter ( lettre d'adressage ): €60 per consultation, fully covered after SS + mutual reimbursement |
| One time/ perpetual license | Pay-as-you-go | Without GP referral: €90 per consultation, partially reimbursed |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Derma Scan product offering
Product offeringCore offering
DermaScan operates dedicated skin cancer screening centers offering systematic total body photography (Cartographie Corporelle Totale) and video dermoscopy examinations, complemented by clinical assessment by trained general practitioners and nurses. Each consultation produces a longitudinal photographic baseline used for change detection across visits, with all imagery and reports made available to patients via a secure online portal.
Product overview
DermaScan is a skin cancer screening service operating as a network of medical centers, offering a unified diagnostic platform centered on Total Body Mapping and dermoscopy technology. The core offering consists of comprehensive body photography (Cartographie Corporelle Totale) combined with digital dermoscopy examination, both supported by a Patient Portal for secure access to results and follow-up images. An AI Companion feature is planned as a future addition to enhance the monitoring capabilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Cartographie Corporelle Totale (Total Body Mapping) A systematic full-body photographic examination (Cartographie Corporelle Totale) that catalogs every mole (size, shape, color, location) using FotoFinder/Canfield technology. Designed for adult patients seeking baseline skin cancer surveillance and longitudinal monitoring across consultations.
- Dermoscopie (Video Dermoscopy) Digital video dermoscopy examination that captures high-magnification images of individual skin lesions, enabling detailed analysis of structures invisible to the naked eye. Each image is tagged to the patient's body map, digitized, archived, and compared across consultations. Intended for adults undergoing skin cancer screening.
Quantifiable outcome
- Availability within 48 hours for most centers (vs. months for dermatology appointments)
- +2 more outcomes
Companies that use Derma Scan
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Derma Scan technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Derma Scan partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DoctolibcoreDoctolib is the exclusive appointment booking platform for all DermaScan centers. All patient scheduling, appointment management, and new patient intake flows exclusively through Doctolib. The partnership provides DermaScan with a high-traffic patient acquisition channel and integrates with the patient's existing Doctolib account (used for identity verification and double authentication).
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Derma Scan competitors and assessment
Company assessmentDirect peers
- SkinVision: Amsterdam-based AI dermatology app that helps users assess skin lesions for cancer risk using smartphone photos and a CE-marked algorithm. Targets the same preventive skin cancer screening use case as DermaScan and competes for the same health-conscious European consumer audience.
- Skin Analytics: UK-based company offering AI-powered skin cancer screening in partnership with NHS and private clinics. Combines teledermatology and clinical-grade AI triage for melanoma detection, addressing the same dermatology access gap that DermaScan targets but with a more digital-first delivery model.
- First Derm: Swedish teledermatology platform connecting users to dermatologists for asynchronous skin lesion assessments. Competes in the European skin cancer screening and triage category with a fully remote delivery model rather than DermaScan's clinic-based approach.
- MoleMap: New Zealand/Australia-based skin cancer screening clinic network using total body photography and dermoscopy in physical locations, with similar patient flow and GP-referral dynamics. Operates a comparable hub-and-spoke screening model with specialist referral pathways, making it the closest international analogue to DermaScan.
Emerging players
- Miiskin: Danish skin tracking app that helps consumers photograph and monitor moles over time, with AI-based mole mapping features. Represents an emerging consumer-facing skin surveillance tool that could serve as an upstream funnel or alternative to DermaScan's body mapping service.
- DermCheck: Online dermatology consultation service that allows users to submit skin photos for review by licensed dermatologists. Targets the same skin cancer screening and general dermatology triage market as DermaScan through a fully remote, asynchronous model rather than physical clinics.
- Aysa: AI-powered dermatology symptom checker app from VisualDX that guides users to possible skin condition matches. Targets similar patient self-triage use cases for skin concerns but does not perform clinical examinations or generate physician reports like DermaScan.
Broad incumbents
- Babylon Health: UK-based digital health incumbent offering AI-assisted triage and telehealth consultations across multiple specialties including dermatology. Operates a much broader portfolio but overlaps with DermaScan's value proposition of providing faster access to skin assessments than traditional GP/dermatology pathways.
- Maple: Canadian telemedicine provider offering on-demand physician consultations including dermatology assessments via image upload. Operates a broader telehealth portfolio but addresses the same skin lesion triage use case DermaScan serves, with overlap in self-paying patients seeking faster access to dermatological advice.
Others
- Doctolib: France's dominant medical appointment booking platform and DermaScan's exclusive scheduling partner. Not a competitor but a critical ecosystem dependency; Doctolib's traffic, identity verification, and double-authentication infrastructure directly underpin DermaScan's patient acquisition and secure portal access.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Derma Scan social profiles
Digital presenceDerma Scan compliance and trust
Trust signalCompliance2 records
Derma Scan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Derma Scan leadership team
Management profileNumber of profiles
Profiles2 records
Derma Scan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Derma Scan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Derma Scan
What does Derma Scan do?
DermaScan operates dedicated skin cancer screening centers offering systematic total body photography (Cartographie Corporelle Totale) and video dermoscopy examinations, complemented by clinical assessment by trained general practitioners and nurses. Each consultation produces a longitudinal photographic baseline used for change detection across visits, with all imagery and reports made available to patients via a secure online portal.
Is Derma Scan a public or private company?
Derma Scan is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Derma Scan founded?
Derma Scan was founded in 2025. It employs 1 to 10 people.
Where is Derma Scan based?
Derma Scan is headquartered in Paris, France, in the Europe region.
How does Derma Scan make money?
One revenue line is on record: skin Cancer Screening Consultations.
Who are Derma Scan's main competitors?
Direct peers on record are SkinVision, Skin Analytics, First Derm and MoleMap. Emerging players are Miiskin, DermCheck and Aysa. Broad incumbents are Babylon Health and Maple. Doctolib is listed as an others.
Does Derma Scan have an API?
No public API is recorded for Derma Scan.
What industry is Derma Scan in?
Derma Scan's product category is Skin Cancer Screening Services. Its primary akta.pro industry code is HLAKACAA, General & Medical Dermatology, with a secondary code of HLAKACAC, Dermatopathology. Its NAICS code is 621511 and its SIC code is 8071.